Stock Research for LXRX

LXRX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

LXRX Stock Chart & Research Data

The LXRX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the LXRX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


LXRX Due diligence Resources & Stock Charts

The LXRX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View LXRX Detailed Price Forecast - CNN Money CNN View LXRX Detailed Summary - Google Finance
Yahoo View LXRX Detailed Summary - Yahoo! Finance Zacks View LXRX Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View LXRX Trends & Analysis - Trade-Ideas Barrons View LXRX Major Holders - Barrons
NASDAQ View LXRX Call Transcripts - NASDAQ Seeking View LXRX Breaking News & Analysis - Seeking Alpha
Spotlight View LXRX Annual Report - CompanySpotlight.com OTC Report View LXRX OTC Short Report - OTCShortReport.com
TradeKing View LXRX Fundamentals - TradeKing Charts View LXRX SEC Filings - Bar Chart
WSJ View Historical Prices for LXRX - The WSJ Morningstar View Performance/Total Return for LXRX - Morningstar
MarketWatch View the Analyst Estimates for LXRX - MarketWatch CNBC View the Earnings History for LXRX - CNBC
StockMarketWatch View the LXRX Earnings - StockMarketWatch MacroAxis View LXRX Buy or Sell Recommendations - MacroAxis
Bullish View the LXRX Bullish Patterns - American Bulls Short Pains View LXRX Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View LXRX Stock Mentions - StockTwits PennyStocks View LXRX Stock Mentions - PennyStockTweets
Twitter View LXRX Stock Mentions - Twitter Invest Hub View LXRX Investment Forum News - Investor Hub
Yahoo View LXRX Stock Mentions - Yahoo! Message Board Seeking Alpha View LXRX Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for LXRX - SECform4.com Insider Cow View Insider Transactions for LXRX - Insider Cow
CNBC View LXRX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for LXRX - OTC Markets
Yahoo View Insider Transactions for LXRX - Yahoo! Finance NASDAQ View Institutional Holdings for LXRX - NASDAQ


Stock Charts

FinViz View LXRX Stock Insight & Charts - FinViz.com StockCharts View LXRX Investment Charts - StockCharts.com
BarChart View LXRX Stock Overview & Charts - BarChart Trading View View LXRX User Generated Charts - Trading View




Latest Financial News for LXRX


See what the IHS Markit Score report has to say about Lexicon Pharmaceuticals Inc.
Posted on Thursday November 15, 2018

Lexicon Pharmaceuticals Inc NASDAQ/NGS:LXRX


Report: Developing Opportunities within Lexicon Pharmaceuticals, Cray, RCI Hospitality, Sanmina, Diamond Offshore Drilling, and Cerus — Future Expectations, Projections Moving into 2018
Posted on Monday November 12, 2018

NEW YORK, Nov. 12, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.


Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
Posted on Thursday November 08, 2018

A live audio webcast for this conference will be available in the “Investors” section of the Lexicon website at www.lexpharma.com/. Lexicon is a fully integrated biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize-winning technology to discover and develop precise medicines for patients with serious, chronic conditions. In addition to its first commercial product, XERMELO® (telotristat ethyl), Lexicon has a pipeline of promising drug candidates in clinical and pre-clinical development in diabetes and metabolism and neuropathic pain.


Edited Transcript of LXRX earnings conference call or presentation 1-Nov-18 12:00pm GMT
Posted on Tuesday November 06, 2018

Q3 2018 Lexicon Pharmaceuticals Inc Earnings Call


Stock Market & Investing Books

Enter a stock symbol to view the stock details.